Chen, Yungchang
Sun, Hao
Deng, Yanhong
Ma, Yutong
Huang, He
Liu, Yang
Zhang, Yaru
Zhang, Hongyu
Ye, Sheng
E, Mingyan
Guo, Hongqiang
Wu, Mengmeng
Wu, Chunman
Pu, Xingxiang
Chen, Xinggui
Liang, Chaoyong
Ou, Qiuxiang
Weng, Huawei
Wu, Xue
Shao, Yang
Gu, Anxin
Lin, Tongyu
Funding for this research was provided by:
Program of Science and Technology of Sichuan Province (2021YFQ0037)
Science Foundation of the Postdoctoral Department of Heilongjiang Province (LBH-Q21118)
Haiyan Research Funding of the Harbin Medical University Cancer Hospital (JJZD2021-03)
Article History
Received: 10 August 2022
Accepted: 15 December 2022
First Online: 25 January 2023
Declarations
:
: This study was approved by the Ethics Committee for Medical Research and New Medical Technology of Sichuan Cancer Hospital (SCCHEC-02-2022-058). Written informed consent was collected from each patient prior to sample collection.
: Written informed consent was obtained from the patients for publication of this study.
: Yutong Ma, Yaru Zhang, Mengmeng Wu, Chunman Wu, Qiuxiang Ou, Xue Wu, and Yang Shao are employees of Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China. The other authors declare no competing financial interests.